Transdermal Med May Directly Target Hostility in Schizophren

Hostility can occur in schizophrenia, even in the absence of psychosis. Transdermal asenapine may directly target this symptom.

Related Keywords

University Of Louisville , Kentucky , United States , New York , Abbvie Allergan , Enteris Biopharma , Rifaat El Mallakh , Leslie Citrome , Eli Lilly , Bristol Myers Squibb , University Of Louisville School Medicine , York Medical College , Boehringer Ingelheim , Novartis , Pfizer , Alkermes , Hisamitsu Pharmaceutical Co Inc , Mood Disorders Research Program , International Journal Of Clinical Practice , Department Of Psychiatry , Noven Pharmaceuticals Inc , Behavioral Sciences , University Of Arizona , Johnson , Lundbeck , New York Medical College , Medscape Medical , Negative Syndrome Scale , Excited Component , Medscape Medical News , Louisville School , Noven Pharmaceuticals , Cadent Therapeutics , Intra Cellular Therapies , Springer Healthcare , International Journal , Clinical Practice , Topic Editor , Clinical Therapeutics , Schizophrenia , Aggression , Anxiety Disorder , Antipsychotics , Neuroleptics , Neuroleptic Drugs , Psychosis , Delusion , Hallucination , Agitation , Affective Disorders , Mood Disorder , Sedation , Transdermal , Transdermal Drug , Rug Transdermal , Paranoid Schizophrenia , Negative Symptoms Of Schizophrenia , Positive Symptoms Of Schizophrenia , Prodromes Of Schizophrenia , Chizophrenia Prodromes ,